Cagrilintide is a powerful, investigational long-acting amylin analog. It is classified as a Dual Amylin and Calcitonin Receptor Agonist (DACRA). Researchers are primarily studying Cagrilintide for its potential role in:
- Satiety and Appetite Control: By activating Amylin Receptors (AMY1) in the brain, it significantly enhances the feeling of fullness, leading to reduced food intake in models.
- Metabolic Regulation: Investigations focus on its effect on slowing gastric emptying, which aids in smoothing post-meal glucose fluctuations.
- Combination Therapy: Studies often explore its synergistic effects when paired with GLP-1 agonists (like Semaglutide) for enhanced weight loss and metabolic improvement.
For a full scientific overview of Cagrilintide, see our research reference page:
Cagrilintide — Overview
Bulk orders automatically save 20% on any 10+ vials (BAC excluded)
Important Notice:
This product is sold strictly for laboratory research purposes only. It is not for human or animal use and not for therapeutic or diagnostic applications.
By purchasing, you confirm that you are a qualified individual using this product in accordance with all applicable laws and research regulations.